 | • レポートコード：QY2108PAL8889 • 出版社/出版日：QYResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける代謝性医薬品の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、代謝性医薬品の種類別市場規模（グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他）、用途別市場規模（病院、小売薬局）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の代謝性医薬品市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における代謝性医薬品の種類別市場規模（2016年-2027年）：グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他 ・世界における代謝性医薬品の用途別市場規模（2016年-2027年）：病院、小売薬局 ・代謝性医薬品の中国市場分析 - 代謝性医薬品の中国市場規模（2016年-2027年） - 中国における代謝性医薬品の主要プレイヤー別市場シェア - 中国における代謝性医薬品の種類別市場規模：グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他 - 中国における代謝性医薬品の用途別市場規模：病院、小売薬局 ・代謝性医薬品の北米市場（2016年-2027年） ・代謝性医薬品のヨーロッパ市場（2016年-2027年） ・代謝性医薬品のアジア太平洋市場（2016年-2027年） ・代謝性医薬品の中南米市場（2016年-2027年） ・代謝性医薬品の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Merck、Novartis、Takeda Pharmaceutical、Astra Zeneca、Beohrigher Ingelheim、KOWA、Kythera、Fuji yakuhin、LG Life Science、Metsubishi Tanabe Pharma ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.
USA is the largest supplier of Metabolism Drugs, with production revenue market share over 43%, while the sales market share is 40%. Europe, following USA, takes production revenue market share of 35% and the sales market share over 23%. That is to say, there are a large number of exports in Europe. Japan is an important market of Drugs for Metabolism Drugs in Asia, accounting for 9% production revenue market share and 10% sales revenue market share of global market.
Players with high-quality products are Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca and Beohrigher Ingelheim, with about 70% market shares.
Market Analysis and Insights: Global and China Metabolism Drugs Market
This report focuses on global and China Metabolism Drugs market.
In 2020, the global Metabolism Drugs market size was US$ 15390 million and it is expected to reach US$ 22080 million by the end of 2027, with a CAGR of 5.3% during 2021-2027. In China the Metabolism Drugs market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Metabolism Drugs Scope and Market Size
Metabolism Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Metabolism Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Metabolism Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Glycogen Metabolism Disease Drug
Lipid Metabolism Disease Drug
Amino Acid Metabolism Drug
Other
Segment by Application
Hospital
Retail Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Merck
Novartis
Takeda Pharmaceutical
Astra Zeneca
Beohrigher Ingelheim
KOWA
Kythera
Fuji yakuhin
LG Life Science
Metsubishi Tanabe Pharma
1 Study Coverage
1.1 Metabolism Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Metabolism Drugs Market Size Growth Rate by Type
1.2.2 Glycogen Metabolism Disease Drug
1.2.3 Lipid Metabolism Disease Drug
1.2.4 Amino Acid Metabolism Drug
1.2.5 Other
1.3 Market by Application
1.3.1 Global Metabolism Drugs Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Metabolism Drugs Market Size, Estimates and Forecasts
2.1.1 Global Metabolism Drugs Revenue 2016-2027
2.1.2 Global Metabolism Drugs Sales 2016-2027
2.2 Global Metabolism Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Metabolism Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Metabolism Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Metabolism Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Metabolism Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Metabolism Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Metabolism Drugs Revenue Forecast by Region (2022-2027)
3 Global Metabolism Drugs Competitor Landscape by Players
3.1 Global Top Metabolism Drugs Manufacturers by Sales
3.1.1 Global Metabolism Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Metabolism Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Metabolism Drugs Manufacturers by Revenue
3.2.1 Key Metabolism Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Metabolism Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Metabolism Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Metabolism Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Metabolism Drugs Revenue in 2020
3.2.6 Global Metabolism Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Metabolism Drugs Price by Manufacturers
3.4 Global Metabolism Drugs Manufacturing Base Distribution, Product Types
3.4.1 Metabolism Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Metabolism Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Metabolism Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Metabolism Drugs Market Size by Type (2016-2021)
4.1.1 Global Metabolism Drugs Sales by Type (2016-2021)
4.1.2 Global Metabolism Drugs Revenue by Type (2016-2021)
4.1.3 Metabolism Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Metabolism Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Metabolism Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Metabolism Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Metabolism Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Metabolism Drugs Market Size by Application (2016-2021)
5.1.1 Global Metabolism Drugs Sales by Application (2016-2021)
5.1.2 Global Metabolism Drugs Revenue by Application (2016-2021)
5.1.3 Metabolism Drugs Price by Application (2016-2021)
5.2 Metabolism Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Metabolism Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Metabolism Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Metabolism Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Metabolism Drugs Market Size YoY Growth 2016-2027
6.1.1 China Metabolism Drugs Sales YoY Growth 2016-2027
6.1.2 China Metabolism Drugs Revenue YoY Growth 2016-2027
6.1.3 China Metabolism Drugs Market Share in Global Market 2016-2027
6.2 China Metabolism Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Metabolism Drugs Players by Sales (2016-2021)
6.2.2 China Top Metabolism Drugs Players by Revenue (2016-2021)
6.3 China Metabolism Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Metabolism Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Metabolism Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Metabolism Drugs Price by Type (2016-2021)
6.4 China Metabolism Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Metabolism Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Metabolism Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Metabolism Drugs Price Forecast by Type (2022-2027)
6.5 China Metabolism Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Metabolism Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Metabolism Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Metabolism Drugs Price by Application (2016-2021)
6.6 China Metabolism Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Metabolism Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Metabolism Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Metabolism Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Metabolism Drugs Market Size YoY Growth 2016-2027
7.2 North America Metabolism Drugs Market Facts & Figures by Country
7.2.1 North America Metabolism Drugs Sales by Country (2016-2021)
7.2.2 North America Metabolism Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Metabolism Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Metabolism Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Metabolism Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Metabolism Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Metabolism Drugs Market Size YoY Growth 2016-2027
9.2 Europe Metabolism Drugs Market Facts & Figures by Country
9.2.1 Europe Metabolism Drugs Sales by Country (2016-2021)
9.2.2 Europe Metabolism Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Metabolism Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Metabolism Drugs Market Facts & Figures by Country
10.2.1 Latin America Metabolism Drugs Sales by Country (2016-2021)
10.2.2 Latin America Metabolism Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Metabolism Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Metabolism Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Metabolism Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Metabolism Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Metabolism Drugs Products Offered
12.1.5 Merck Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Metabolism Drugs Products Offered
12.2.5 Novartis Recent Development
12.3 Takeda Pharmaceutical
12.3.1 Takeda Pharmaceutical Corporation Information
12.3.2 Takeda Pharmaceutical Description and Business Overview
12.3.3 Takeda Pharmaceutical Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takeda Pharmaceutical Metabolism Drugs Products Offered
12.3.5 Takeda Pharmaceutical Recent Development
12.4 Astra Zeneca
12.4.1 Astra Zeneca Corporation Information
12.4.2 Astra Zeneca Description and Business Overview
12.4.3 Astra Zeneca Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Astra Zeneca Metabolism Drugs Products Offered
12.4.5 Astra Zeneca Recent Development
12.5 Beohrigher Ingelheim
12.5.1 Beohrigher Ingelheim Corporation Information
12.5.2 Beohrigher Ingelheim Description and Business Overview
12.5.3 Beohrigher Ingelheim Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Beohrigher Ingelheim Metabolism Drugs Products Offered
12.5.5 Beohrigher Ingelheim Recent Development
12.6 KOWA
12.6.1 KOWA Corporation Information
12.6.2 KOWA Description and Business Overview
12.6.3 KOWA Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 KOWA Metabolism Drugs Products Offered
12.6.5 KOWA Recent Development
12.7 Kythera
12.7.1 Kythera Corporation Information
12.7.2 Kythera Description and Business Overview
12.7.3 Kythera Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Kythera Metabolism Drugs Products Offered
12.7.5 Kythera Recent Development
12.8 Fuji yakuhin
12.8.1 Fuji yakuhin Corporation Information
12.8.2 Fuji yakuhin Description and Business Overview
12.8.3 Fuji yakuhin Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Fuji yakuhin Metabolism Drugs Products Offered
12.8.5 Fuji yakuhin Recent Development
12.9 LG Life Science
12.9.1 LG Life Science Corporation Information
12.9.2 LG Life Science Description and Business Overview
12.9.3 LG Life Science Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 LG Life Science Metabolism Drugs Products Offered
12.9.5 LG Life Science Recent Development
12.10 Metsubishi Tanabe Pharma
12.10.1 Metsubishi Tanabe Pharma Corporation Information
12.10.2 Metsubishi Tanabe Pharma Description and Business Overview
12.10.3 Metsubishi Tanabe Pharma Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Metsubishi Tanabe Pharma Metabolism Drugs Products Offered
12.10.5 Metsubishi Tanabe Pharma Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck Metabolism Drugs Products Offered
12.11.5 Merck Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Metabolism Drugs Industry Trends
13.2 Metabolism Drugs Market Drivers
13.3 Metabolism Drugs Market Challenges
13.4 Metabolism Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Metabolism Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Metabolism Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Glycogen Metabolism Disease Drug
Table 3. Major Manufacturers of Lipid Metabolism Disease Drug
Table 4. Major Manufacturers of Amino Acid Metabolism Drug
Table 5. Major Manufacturers of Other
Table 6. Global Metabolism Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 7. Global Metabolism Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Metabolism Drugs Sales by Regions (2016-2021) & (K Units)
Table 9. Global Metabolism Drugs Sales Market Share by Regions (2016-2021)
Table 10. Global Metabolism Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Metabolism Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 12. Global Metabolism Drugs Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Metabolism Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Metabolism Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Metabolism Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 16. Global Metabolism Drugs Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Metabolism Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 18. Metabolism Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Metabolism Drugs Revenue Share by Manufacturers (2016-2021)
Table 20. Global Metabolism Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Metabolism Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolism Drugs as of 2020)
Table 22. Key Manufacturers Metabolism Drugs Price (2016-2021) (USD/Unit)
Table 23. Metabolism Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Metabolism Drugs Product Type
Table 25. Date of International Manufacturers Enter into Metabolism Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Metabolism Drugs Sales by Type (2016-2021) (K Units)
Table 28. Global Metabolism Drugs Sales Share by Type (2016-2021)
Table 29. Global Metabolism Drugs Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Metabolism Drugs Revenue Share by Type (2016-2021)
Table 31. Metabolism Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 32. Global Metabolism Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 33. Global Metabolism Drugs Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Metabolism Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Metabolism Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Metabolism Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 37. Global Metabolism Drugs Sales by Application (2016-2021) (K Units)
Table 38. Global Metabolism Drugs Sales Share by Application (2016-2021)
Table 39. Global Metabolism Drugs Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Metabolism Drugs Revenue Share by Application (2016-2021)
Table 41. Metabolism Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 42. Global Metabolism Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 43. Global Metabolism Drugs Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Metabolism Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Metabolism Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Metabolism Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 47. China Metabolism Drugs Sales (K Units) of Key Companies (2016-2021)
Table 48. China Metabolism Drugs Sales Share by Company (2016-2021)
Table 49. China Metabolism Drugs Revenue (US$ Million) by Company (2016-2021)
Table 50. China Metabolism Drugs Revenue Share by Company (2016-2021)
Table 51. China Metabolism Drugs Sales (K Units) by Type (2016-2021)
Table 52. China Metabolism Drugs Sales Share by Type (2016-2021)
Table 53. China Metabolism Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Metabolism Drugs Price (USD/Unit) by Type (2016-2021)
Table 55. China Metabolism Drugs Sales (K Units) by Type (2022-2027)
Table 56. China Metabolism Drugs Sales Share by Type (2022-2027)
Table 57. China Metabolism Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Metabolism Drugs Revenue Share by Type (2022-2027)
Table 59. China Metabolism Drugs Price (USD/Unit) by Type (2022-2027)
Table 60. China Metabolism Drugs Sales (K Units) by Application (2016-2021)
Table 61. China Metabolism Drugs Sales Share by Application (2016-2021)
Table 62. China Metabolism Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Metabolism Drugs Price (USD/Unit) by Application (2016-2021)
Table 64. China Metabolism Drugs Sales (K Units) by Application (2022-2027)
Table 65. China Metabolism Drugs Sales Share by Application (2022-2027)
Table 66. China Metabolism Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Metabolism Drugs Revenue Share by Application (2022-2027)
Table 68. China Metabolism Drugs Price (USD/Unit) by Application (2022-2027)
Table 69. North America Metabolism Drugs Sales by Country (2016-2021) & (K Units)
Table 70. North America Metabolism Drugs Sales Market Share by Country (2016-2021)
Table 71. North America Metabolism Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Metabolism Drugs Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Metabolism Drugs Sales by Region (2016-2021) & (K Units)
Table 74. Asia Pacific Metabolism Drugs Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Metabolism Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Metabolism Drugs Revenue Market Share by Region (2016-2021)
Table 77. Europe Metabolism Drugs Sales by Country (2016-2021) & (K Units)
Table 78. Europe Metabolism Drugs Sales Market Share by Country (2016-2021)
Table 79. Europe Metabolism Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Metabolism Drugs Revenue Market Share by Country (2016-2021)
Table 81. Latin America Metabolism Drugs Sales by Country (2016-2021) & (K Units)
Table 82. Latin America Metabolism Drugs Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Metabolism Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Metabolism Drugs Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Metabolism Drugs Sales by Country (2016-2021) & (K Units)
Table 86. Middle East and Africa Metabolism Drugs Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Metabolism Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Metabolism Drugs Revenue Market Share by Country (2016-2021)
Table 89. Merck Corporation Information
Table 90. Merck Description and Business Overview
Table 91. Merck Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 92. Merck Metabolism Drugs Product
Table 93. Merck Recent Development
Table 94. Novartis Corporation Information
Table 95. Novartis Description and Business Overview
Table 96. Novartis Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 97. Novartis Product
Table 98. Novartis Recent Development
Table 99. Takeda Pharmaceutical Corporation Information
Table 100. Takeda Pharmaceutical Description and Business Overview
Table 101. Takeda Pharmaceutical Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 102. Takeda Pharmaceutical Product
Table 103. Takeda Pharmaceutical Recent Development
Table 104. Astra Zeneca Corporation Information
Table 105. Astra Zeneca Description and Business Overview
Table 106. Astra Zeneca Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 107. Astra Zeneca Product
Table 108. Astra Zeneca Recent Development
Table 109. Beohrigher Ingelheim Corporation Information
Table 110. Beohrigher Ingelheim Description and Business Overview
Table 111. Beohrigher Ingelheim Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 112. Beohrigher Ingelheim Product
Table 113. Beohrigher Ingelheim Recent Development
Table 114. KOWA Corporation Information
Table 115. KOWA Description and Business Overview
Table 116. KOWA Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 117. KOWA Product
Table 118. KOWA Recent Development
Table 119. Kythera Corporation Information
Table 120. Kythera Description and Business Overview
Table 121. Kythera Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 122. Kythera Product
Table 123. Kythera Recent Development
Table 124. Fuji yakuhin Corporation Information
Table 125. Fuji yakuhin Description and Business Overview
Table 126. Fuji yakuhin Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 127. Fuji yakuhin Product
Table 128. Fuji yakuhin Recent Development
Table 129. LG Life Science Corporation Information
Table 130. LG Life Science Description and Business Overview
Table 131. LG Life Science Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 132. LG Life Science Product
Table 133. LG Life Science Recent Development
Table 134. Metsubishi Tanabe Pharma Corporation Information
Table 135. Metsubishi Tanabe Pharma Description and Business Overview
Table 136. Metsubishi Tanabe Pharma Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 137. Metsubishi Tanabe Pharma Product
Table 138. Metsubishi Tanabe Pharma Recent Development
Table 139. Metabolism Drugs Market Trends
Table 140. Metabolism Drugs Market Drivers
Table 141. Metabolism Drugs Market Challenges
Table 142. Metabolism Drugs Market Restraints
Table 143. Metabolism Drugs Customers List
Table 144. Metabolism Drugs Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Metabolism Drugs Product Picture
Figure 2. Global Metabolism Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Glycogen Metabolism Disease Drug Product Picture
Figure 4. Lipid Metabolism Disease Drug Product Picture
Figure 5. Amino Acid Metabolism Drug Product Picture
Figure 6. Other Product Picture
Figure 7. Global Metabolism Drugs Sales Market Share by Application in 2020 & 2027
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Metabolism Drugs Report Years Considered
Figure 11. Global Metabolism Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Metabolism Drugs Market Size 2016-2027 (US$ Million)
Figure 13. Global Metabolism Drugs Sales 2016-2027 (K Units)
Figure 14. Global Metabolism Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Metabolism Drugs Sales Market Share by Region (2016-2021)
Figure 16. Global Metabolism Drugs Sales Market Share by Region in 2020
Figure 17. Global Metabolism Drugs Revenue Market Share by Region (2016-2021)
Figure 18. Global Metabolism Drugs Revenue Market Share by Region in 2020
Figure 19. Global Metabolism Drugs Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Metabolism Drugs Revenue in 2020
Figure 21. Metabolism Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Metabolism Drugs Sales Market Share by Type (2016-2021)
Figure 23. Global Metabolism Drugs Sales Market Share by Type in 2020
Figure 24. Global Metabolism Drugs Revenue Market Share by Type (2016-2021)
Figure 25. Global Metabolism Drugs Revenue Market Share by Type in 2020
Figure 26. Global Metabolism Drugs Sales Market Share by Application (2016-2021)
Figure 27. Global Metabolism Drugs Sales Market Share by Application in 2020
Figure 28. Global Metabolism Drugs Revenue Market Share by Application (2016-2021)
Figure 29. Global Metabolism Drugs Revenue Market Share by Application in 2020
Figure 30. China Metabolism Drugs Sales Growth Rate 2016-2027 (K Units)
Figure 31. China Metabolism Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Metabolism Drugs Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Metabolism Drugs Players Market Share by Revenue in Metabolism Drugs in 2020
Figure 34. China Metabolism Drugs Revenue Share by Type (2016-2021)
Figure 35. China Metabolism Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Metabolism Drugs Revenue Share by Application (2016-2021)
Figure 37. China Metabolism Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Metabolism Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 39. North America Metabolism Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Metabolism Drugs Sales Market Share by Country in 2020
Figure 41. North America Metabolism Drugs Revenue Market Share by Country in 2020
Figure 42. U.S. Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 43. U.S. Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 45. Canada Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Metabolism Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 47. Europe Metabolism Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Metabolism Drugs Sales Market Share by Country in 2020
Figure 49. Europe Metabolism Drugs Revenue Market Share by Country in 2020
Figure 50. Germany Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 51. Germany Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 53. France Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 55. U.K. Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 57. Italy Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 59. Russia Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Metabolism Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 61. Asia Pacific Metabolism Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Metabolism Drugs Sales Market Share by Region in 2020
Figure 63. Asia Pacific Metabolism Drugs Revenue Market Share by Region in 2020
Figure 64. China Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 65. China Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 67. Japan Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 69. South Korea Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 71. India Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 73. Australia Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 75. Taiwan Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 77. Indonesia Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 79. Thailand Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 81. Malaysia Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Philippines Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 83. Philippines Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Vietnam Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 85. Vietnam Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Metabolism Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 87. Latin America Metabolism Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Metabolism Drugs Sales Market Share by Country in 2020
Figure 89. Latin America Metabolism Drugs Revenue Market Share by Country in 2020
Figure 90. Mexico Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 91. Mexico Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 93. Brazil Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 95. Argentina Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Metabolism Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 97. Middle East and Africa Metabolism Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Metabolism Drugs Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Metabolism Drugs Revenue Market Share by Country in 2020
Figure 100. Turkey Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 101. Turkey Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 103. Saudi Arabia Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. U.A.E Metabolism Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 105. U.A.E Metabolism Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Metabolism Drugs Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
代謝薬の世界市場 2020年 Market Overview The Metabolism Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…- 代謝試験の世界市場 2020年 Market Overview The global Metabolism Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metabolism Testing market …
- メニエール病治療薬の世界市場 2020年 Market Overview The global Meniere Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meniere Disease Drugs m…
- 末期腎疾患（ESRD）用治療薬の世界市場 2020年 Market Overview The global End-Stage Renal Disease (ESRD) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The End-Stag…
- 感染症治療薬の世界市場 2020年 Market Overview The global Infectious Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Infectious Disease D…